79 related articles for article (PubMed ID: 3984229)
1. [Age--a prognostic factor in Hodgkin's disease].
Dienstbier Z; Dvorák P; Barták P; Hermanská Z; Foltýnová V
Vnitr Lek; 1985 Feb; 31(2):160-5. PubMed ID: 3984229
[No Abstract] [Full Text] [Related]
2. Survival after recurrence: prognostic factors and spread patterns in clinical stages I and II of Hodgkin's disease.
Tubiana M; van der Werf-Messing B; Laugier A; Hayat M; Henry-Amar M; Attie E; Leroy T
Natl Cancer Inst Monogr; 1973 May; 36():513-30. PubMed ID: 4744607
[No Abstract] [Full Text] [Related]
3. [Evaluation of prognostic factors in Hodgkin's disease. Experience of the comprehensive rationale team in treating patients with Hodgkin's disease].
Foltýnová V
Cas Lek Cesk; 1986 May; 125(22):684-90. PubMed ID: 3708676
[No Abstract] [Full Text] [Related]
4. Interrelationship between several prognostic factors in Hodgkin's disease.
Kotlarek-Haus S; Gabryś K; Starzyk H; Sciborski R; Gałazka Z
Arch Geschwulstforsch; 1982; 52(4):293-301. PubMed ID: 7138241
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of the clinical indicators in Hodgkin's disease].
Baĭsogolov GD; Khmelevskaia ZI; Shishkin IP
Vestn Akad Med Nauk SSSR; 1978; (1):54-9. PubMed ID: 626026
[No Abstract] [Full Text] [Related]
6. Hodgkin's and non-Hodgkin's lymphomas.
McElwain TJ
Br J Hosp Med; 1984 Jan; 31(1):10-4, 18-9. PubMed ID: 6697038
[No Abstract] [Full Text] [Related]
7. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in pathologic stage III Hodgkin's disease.
Hoppe RT; Cox RS; Rosenberg SA; Kaplan HS
Cancer Treat Rep; 1982 Apr; 66(4):743-9. PubMed ID: 7074644
[No Abstract] [Full Text] [Related]
9. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
10. Primary management of Hodgkin's disease.
Aisenberg AC
N Engl J Med; 1968 Jan; 278(2):93-5. PubMed ID: 4863778
[No Abstract] [Full Text] [Related]
11. [The significance of mediastinal involvement and other risk factors for survival in patients with Hodgkin's disease].
Melínova L; Hermanská Z; Halíková J; Dienstbier Z; Vacková B; Zámecník J; Skala E
Vnitr Lek; 1995 May; 41(5):307-12. PubMed ID: 7653060
[TBL] [Abstract][Full Text] [Related]
12. [Laparotomy and splenectomy in Hodgkin's disease].
Nikkanen V; Ojala A; Linna MI
Duodecim; 1974; 90(3):178-85. PubMed ID: 4849043
[No Abstract] [Full Text] [Related]
13. Statistical procedures for evaluating survival in Hodgkin's disease.
Myers MH; Axtell LM
Natl Cancer Inst Monogr; 1973 May; 36():555-9. PubMed ID: 4800297
[No Abstract] [Full Text] [Related]
14. [Long-term (over 10-years) survival in Hodgkin's disease].
Kotlarek-Haus S; Gabryś K; Kuliszkiewicz-Janus M; Potoczek S; Kiełbiński M
Acta Haematol Pol; 1993; 24(1):35-42. PubMed ID: 8488735
[TBL] [Abstract][Full Text] [Related]
15. Survival and relapse rates in Hodgkin's disease: Stanford experience, 1961-71.
Kaplan HS
Natl Cancer Inst Monogr; 1973 May; 36():487-96. PubMed ID: 4126721
[No Abstract] [Full Text] [Related]
16. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
Brice P; Bouabdallah R; Moreau P; Divine M; André M; Aoudjane M; Fleury J; Anglaret B; Baruchel A; Sensebe L; Colombat P
Bone Marrow Transplant; 1997 Jul; 20(1):21-6. PubMed ID: 9232251
[TBL] [Abstract][Full Text] [Related]
17. Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma.
Kewalramani T; Nimer SD; Zelenetz AD; Malhotra S; Qin J; Yahalom J; Moskowitz CH
Bone Marrow Transplant; 2003 Oct; 32(7):673-9. PubMed ID: 13130314
[TBL] [Abstract][Full Text] [Related]
18. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
[TBL] [Abstract][Full Text] [Related]
19. Outcome in Hodgkin's disease: a 20-year cohort of patients.
Ranaghan L; Markey GM; Morris TC
Ulster Med J; 1998 Nov; 67(2):91-8. PubMed ID: 9885544
[TBL] [Abstract][Full Text] [Related]
20. [Curableness of Hodgkin's disease].
Glińska H
Folia Med Cracov; 1971; 13(4):445-500. PubMed ID: 5139805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
